Table 3. Treatment outcomes of ¹⁰⁶Ru plaque therapy.

Treatment outcomes	n=25
BCVA, ETDRS (letters)
Baseline	41.4±29.3
The last follow-up visit	53.0±33.8
Pa	0.01
BCVA improved or stable, n (%)	24 (96)
Tumor dimension on USG
Height, mm
Baseline	3.98±0.88
The last follow-up visit	0.84±1.63
Pa	≤0.001
GLD, mm
Baseline	9.36±2.23
The last follow-up visit	7.40±2.45
Pa	≤0.001
Complete SRF resolution, n (%)	24 (96)
Recurrence, n (%)	0

BCVA: Best-corrected visual acuity; ETDRS: The Early Treatment Diabetic Retinopathy Study; USG: Ultrasonography; GLD: The greatest linear diameter; SRF: Subretinal fluid. ^aP value using the paired Student's t-test.